Applicability of international prognostic index in NON HODGKIN’S LYMPHOMA IN PAKISTAN
AbstractBackground: Aggressive non Hodgkin’s Lymphomas (NHL) are common in Southeast Asia, Middle East and Africa. Data on survival with relation to prognostic factors is scarce. The primary objective of the study was to evaluate the applicability of International Prognostic Index (IPI) to predict overall survival (OS) and disease free survival (DFS) in developing countries. Methods: Two hundred and nineteen patients of NHL consecutively presenting to the Department of Oncology, Jinnah Hospital Lahore between August 1998 to July 2000 were analyzed. All patients underwent initial staging according to Ann Arbor staging system. The patients were categorized by five independent risk factors: patient age, disease stage, serum lactate dehydrogenase (LDH) levels, performance status, and number of extranodal sites involved. Patients were divided into three risk categories Low (0 or one risk factors), Intermediate (2 risk factors) and High (3 or more risk factors). Results: According to IPI low risk category comprised of 15%, intermediate 21% and high 64% of patients, Overall survival (OS) for 2 years and 5 years (n=197) was (69%), (51%), (32%) and (64%), (46%), (13%) respectively (p=0.0008). Disease free survival (DFS) for 2 years and five years (n=197) was (66%), (43%), (34%) and (66%), (43%), (18%) respectively. Age adjusted (≤ 60) DFS for 2 and 5 years (n=164) was (70%), (45%), (40%) and (63%), (45%) (19%)respectively. OS for 2 and 5 years (n=164) was (71%), (52%), (34%) and (64%), (46%),(11%) respectively (p=0.0013). Conclusions: The IPI accurately predicted survival in our population. Modification of treatment protocols according to specific risk groups will be beneficial to the developing countries with limited resources.Key Words: Developing Countries, International Prognostic Index, Survival, Non Hodgkin’s Lymphoma
Greenlee RT, Murray T, Bolden S. Cancer statistics 2000. CA Cancer J Clin 2000; 50: 7-33.
Parkin DM, Pisani P, Ferlay J. Global Cancer Statistics,1999. CA Cancer J Clin 1999;49:33-64 .
Intragumtornchai T, Wannakrairoj P, Chaimongkol B. NHL in Thailand. A retrospective pathologic and clinical analysis of 1391 cases. Cancer 1996;78(8):1813-9.
Ji X, Li W.Malignant lymphoma in Beijing. J Environ Pathol Toxicol Oncol 1992;11(5-6):327-9
Chi JG, Shin SS, Ahn GH. Malignant lymphomas in Korea. Jpn J Clin Oncol 1985;15:653-7.
Obafunwa JO, Akinsete I. Malignant lymphomas in Jos, Nigeria: a ten-year study. Cent Afr J Med 1992;38(1):17-25.
Jussawalla DJ, Gangadharan P. Epidemiology of Cancer in the Indian subcontinent, series IV. Indian J Cancer 1974; 11:3-11.
Ahmad M, Khan AH, Mansoor A. NHL clinicopathological pattern. J Pak Med Assoc 1992;42:205-09.
The International NHL Prognostic Factors Project. A Predictive Model for aggressive Non-Hodgkins Lymphoma. N Engl J Med 1993;329(14):987-94.
Rajajee S, Desikulu MV, Pushpa V. Survival of childhood acute lymphoblastic leukemia: experience in Chennai. J Trop Pediatr 1999;45(6):367-70.
Overview of Economic Survey 2001-2002 by the Government of Pakistan. Dawn, June 14, 2002.
Cheson B, Horning S. Report of an international workshop to standardize response criteria for NHL. J Clin Oncol 1999;17(4):1244-53.
Aydin F, Ulosoy S, Ovali E. Results of treatment with Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone(CHOP) for non-Hodgkins aggressive lymphoma analyzed accorsing to the IPI. Journal Chemotherapy 1997;9(6):446-51.
Mounier N, Morel P, Haioun C. A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d’Etudes lymphomas de l’Adulte. Cancer 1998; 82(10):1952-62.
Salmenin E. Age related survival in NHL. Oncology 1998;55(1):7-9.
Peters FP, Haaft MA, Schouten HC. Intermediate and high grade NHL in the elderly. Leuk Lymphoma 1999;33(3-4): 243-52.
Atkins CD, Myers CD. A predictive model for NHL. [correspondence]. N Engl J Med 1994;330(8):574-5.
Lee SC, Wong JE, Kueh YK. Clinical characteristics and treatment outcome of 218 patients with NHL in a Singaporean institution. Singapore Med J 2000;41(3):118-21.
Shipp M. Prognostic Factors in Aggressive NHL: Who Has “ High –Risk” Disease? Blood 1994;83(5):1165-73.
Phillip T, Gomez F, Guglielmi C. Long-term outcome of relapsed NHL patients included in the PARMA TRIAL: incidence of late relapses, long-term toxicity and impact of the international prognostic index (IPI) at relapse. Proc Am Soc Clin Oncol 1998;17:16a.
Garg A, Dawar R, Agarwal V. NHL in Northern India: A retrospective analysis of 238 cases. Cancer 1985;56:972-7.
Salem P, Anaissie E, Allam C. NHL in the Middle East, A study of 417 patients with emphasis on special features. Cancer 1986;58:1162-6.
Aziz Z, Rehman A, Akram M. NHL in Pakistan: a clinical profile of 175 patients. J Pak Med Assoc 1999;49(1):
Chim CS, Kwong YL, Lie AK, Lee CK, Liang R. CEOP treatment results and validation of the International prognostic Index in Chinese patients with aggressive NHL. Hematol Oncol 1998;16(3):117-23.
Yong W, Zhang YT, Wei Y. Multivariate analysis on prognostic factors of NHL (article in Chinese). Zhonghua Zhong Liu Za Zhi 1997;19(3):212-4.
Chin Mok TS, Steinberg J, Chan AT, Yeo WM, Hui P, Leung TW, Johnson R. Application of the IPI in a study of Chinese patients with NHL and a high incidence of primary extranodal lymphoma.. Cancer 1998;82(12):2439-48.
Biosoli I, Morais JC, Soares de Jesus P, Pulcheri W, Nucci M, Spector N. Application of an adopted international prognostic index for aggressive NHL: good discrimination and lower survival rates in Rio de Janerio, Brazil. Oncol Rep 2001;8(2):441-4.
Ghafoor A. An overview of research on communicable disease in Pakistan. Proc. PMRC Med. Res. Congr., Islamabad 1984; 29-39.
Ferraz EM, Gray RH, Cunha TM. Determinants of pre-term delivery and intrauterine growth retardation in northeast Brazil. Int J Epidemiol 1990;19:101-8.
Lima M, Figueira F, Ebrahim GJ. Malnutrition among children of adolescent mothers in a squatter community of Recife. Brazil J Trop Pediatr 1990;36:14-19.
Robyn C, Kieta MS, Neuris S, Intrauterine growth retardation in Africa. In: Senterre J (ed). Intrauterine Growth Retardation. Nestle nutrition Workshop Series 18. New York, Netsec Ltd Vevey/Raven Press 1989: pp165-181.
Viana MB, Fernandes RA, de Carvalho RI, Murao M. Low socioeconomic status is a strong independent predictor of relapse in childhood acute lymphoblastic leukemia. Int J Cancer Suppl 1998;11:56-61
World Development Report. Investing in Health. World Development Indicators. New York, Oxford University Press, 1993.(soc. Indicators).